Abivax (ABVX) Other financing activities (2024 - 2026)

Abivax's Other financing activities history runs 3 years deep, the most recent figure standing at $9366.0 for Q1 2026.

• In Q1 2026, Other financing activities fell 96.44% year-over-year to $9366.0; the TTM figure through Mar 2026 stood at $65963.9 (down 87.4% YoY), while the FY2025 annual figure was $349213.1, up 33.39% from the prior year.
• Other financing activities was $9366.0 for Q1 2026 at Abivax, down from $56598.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $262971.1 in Q1 2025 to a low of $1098.2 in Q3 2024.
• Historically, Other financing activities has averaged $98803.7 across 3 years, with a median of $32982.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Other financing activities soared 7968.86% in 2025, then tumbled 96.44% in 2026.
• A 3-year view of Other financing activities shows it stood at $1098.2 in 2024, then jumped by 5053.61% to $56598.0 in 2025, then slumped by 83.45% to $9366.0 in 2026.
• The last three Other financing activities figures came in at $9366.0 (Q1 2026), $56598.0 (Q2 2025), and $262971.1 (Q1 2025), per Business Quant data.